NO993868L - 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme - Google Patents
3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende sammeInfo
- Publication number
- NO993868L NO993868L NO993868A NO993868A NO993868L NO 993868 L NO993868 L NO 993868L NO 993868 A NO993868 A NO 993868A NO 993868 A NO993868 A NO 993868A NO 993868 L NO993868 L NO 993868L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- piperidyl
- group
- ldl
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP36281997 | 1997-12-12 | ||
JP10288979A JP2959765B2 (ja) | 1997-12-12 | 1998-10-12 | 3−ピペリジル−4−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物 |
PCT/JP1998/005628 WO1999031085A1 (fr) | 1997-12-12 | 1998-12-11 | Derives du 3-piperidyl-4-oxoquinazoline et compositions medicinales les contenant |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993868D0 NO993868D0 (no) | 1999-08-11 |
NO993868L true NO993868L (no) | 1999-10-12 |
Family
ID=26557408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993868A NO993868L (no) | 1997-12-12 | 1999-08-11 | 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme |
Country Status (18)
Country | Link |
---|---|
US (1) | US6235730B1 (fr) |
EP (1) | EP0970954A4 (fr) |
JP (1) | JP2959765B2 (fr) |
KR (1) | KR20000070983A (fr) |
CN (1) | CN1252068A (fr) |
AR (1) | AR009212A1 (fr) |
AU (1) | AU717963B2 (fr) |
BR (1) | BR9807339A (fr) |
CA (1) | CA2280705A1 (fr) |
HU (1) | HUP0001154A3 (fr) |
ID (1) | ID23439A (fr) |
IL (1) | IL131319A0 (fr) |
NO (1) | NO993868L (fr) |
NZ (1) | NZ337118A (fr) |
PE (1) | PE20000054A1 (fr) |
SK (1) | SK109399A3 (fr) |
TR (1) | TR199901933T1 (fr) |
WO (1) | WO1999031085A1 (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6767739B2 (en) | 2001-07-30 | 2004-07-27 | Isis Pharmaceuticals Inc. | Antisense modulation of microsomal triglyceride transfer protein expression |
US20040122011A1 (en) * | 1998-12-23 | 2004-06-24 | Pharmacia Corporation | Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy |
USPP12295P2 (en) * | 1999-06-01 | 2001-12-18 | Florfis Ag | Geranium plant named ‘Fiscoral’ |
US6258819B1 (en) * | 1999-08-05 | 2001-07-10 | Syntex (U.S.A.) Llc | Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones |
JP2003104971A (ja) * | 1999-08-12 | 2003-04-09 | Wakunaga Pharmaceut Co Ltd | 新規アニリド誘導体又はその塩及びこれを含有する医薬 |
EP1255735A2 (fr) * | 2000-02-03 | 2002-11-13 | Eli Lilly And Company | Agents de potentialisation de recepteurs de glutamate |
US20040048780A1 (en) * | 2000-05-10 | 2004-03-11 | The Trustees Of Columbia University In The City Of New York | Method for treating and preventing cardiac arrhythmia |
US6489125B1 (en) * | 2000-05-10 | 2002-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor |
US7393652B2 (en) * | 2000-05-10 | 2008-07-01 | The Trustees Of Columbia University In The City Of New York | Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2) |
US7879840B2 (en) * | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US7718644B2 (en) * | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
US20040229781A1 (en) * | 2000-05-10 | 2004-11-18 | Marks Andrew Robert | Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias |
US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US20060293266A1 (en) * | 2000-05-10 | 2006-12-28 | The Trustees Of Columbia | Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure |
KR100575944B1 (ko) | 2001-06-28 | 2006-05-02 | 화이자 프로덕츠 인코포레이티드 | 미소체 트리글리세라이드 전달 단백질(mtp) 및/또는아포지방단백질 b(apo b)분비의 억제제로서의트리아미드-치환된 인돌, 벤조푸란 및 벤조티오펜 |
SG165154A1 (en) | 2002-02-28 | 2010-10-28 | Japan Tobacco Inc | Ester compound and medical use thereof |
US7544678B2 (en) * | 2002-11-05 | 2009-06-09 | The Trustees Of Columbia University In The City Of New York | Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
JP2007525165A (ja) | 2003-03-07 | 2007-09-06 | トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | タイプ1ライアノジン受容体に基づく方法 |
EP1669345A4 (fr) | 2003-08-29 | 2008-02-20 | Japan Tobacco Inc | Derive d'ester et utilisation medicale de celui-ci |
JP4773969B2 (ja) * | 2003-10-08 | 2011-09-14 | イーライ リリー アンド カンパニー | 脂質代謝異常の治療ための化合物及び方法 |
US8710045B2 (en) * | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
US7417040B2 (en) * | 2004-03-01 | 2008-08-26 | Bristol-Myers Squibb Company | Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US7378426B2 (en) * | 2004-03-01 | 2008-05-27 | Bristol-Myers Squibb Company | Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
US8101774B2 (en) | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
AU2005297923B2 (en) * | 2004-10-25 | 2010-12-23 | Japan Tobacco Inc. | Solid medicinal preparation improved in solubility and stability and process for producing the same |
WO2006129193A2 (fr) * | 2005-05-27 | 2006-12-07 | Pfizer Products Inc. | Polytherapie pour le traitement de l'obesite ou le maintien du poids apres une perte ponderale |
US7704990B2 (en) * | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
US20070105835A1 (en) * | 2005-11-07 | 2007-05-10 | Kazantsev Aleksey G | Compositions and methods for modulating poly(ADP-ribose) polymerase activity |
WO2007132841A1 (fr) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | Composé hétérocyclique fusionné et utilisation |
ATE509956T1 (de) * | 2006-06-08 | 2011-06-15 | Helmholtz Zentrum Muenchen | Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie |
CN101547922B (zh) * | 2006-10-04 | 2012-06-20 | 辉瑞产品公司 | 作为钙受体拮抗剂的吡啶并[4,3-d]嘧啶-4(3H)-酮衍生物 |
US8735391B2 (en) | 2008-09-26 | 2014-05-27 | University Of Kansas | Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods |
WO2014102592A2 (fr) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Composés de pipéridine de type quinoxaline substituée par oxime et leurs utilisations |
CN109641884B (zh) * | 2016-08-18 | 2024-01-02 | 维达克制药有限公司 | 哌嗪衍生物、其药物组合物及其使用方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1583753A (en) * | 1976-07-14 | 1981-02-04 | Science Union & Cie | Piperidine derivatives processes for their preparation and pharmaceutical compositions containing them |
US4292321A (en) | 1979-05-24 | 1981-09-29 | Warner-Lambert Company | 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof |
US4364954A (en) | 1980-01-10 | 1982-12-21 | Warner-Lambert Company | Diphenylpropanamines, compositions thereof and use thereof |
HU218419B (hu) | 1992-03-06 | 2000-08-28 | E.R. Squibb And Sons, Inc. | Mikroszomális triglicerid transzfer protein (MTP) nagy molekulatömegű alegységének rekombináns úton történő előállítására és a protein és inhibitorainak kimutatására szolgáló eljárások |
US5595872A (en) | 1992-03-06 | 1997-01-21 | Bristol-Myers Squibb Company | Nucleic acids encoding microsomal trigyceride transfer protein |
US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
JPH08151377A (ja) | 1994-11-25 | 1996-06-11 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体 |
US5919795A (en) | 1995-06-07 | 1999-07-06 | Pfizer Inc. | Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and their use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion |
DE19546918A1 (de) | 1995-12-15 | 1997-06-19 | Bayer Ag | Bicyclische Heterocyclen |
DE19615262A1 (de) | 1996-04-18 | 1997-10-23 | Bayer Ag | Heteroverknüpfte Phenylglycinolamide |
-
1998
- 1998-10-12 JP JP10288979A patent/JP2959765B2/ja not_active Expired - Lifetime
- 1998-12-11 NZ NZ337118A patent/NZ337118A/xx unknown
- 1998-12-11 SK SK1093-99A patent/SK109399A3/sk unknown
- 1998-12-11 TR TR1999/01933T patent/TR199901933T1/xx unknown
- 1998-12-11 KR KR1019997007249A patent/KR20000070983A/ko not_active Application Discontinuation
- 1998-12-11 BR BR9807339A patent/BR9807339A/pt not_active IP Right Cessation
- 1998-12-11 WO PCT/JP1998/005628 patent/WO1999031085A1/fr not_active Application Discontinuation
- 1998-12-11 CA CA002280705A patent/CA2280705A1/fr not_active Abandoned
- 1998-12-11 HU HU0001154A patent/HUP0001154A3/hu unknown
- 1998-12-11 IL IL13131998A patent/IL131319A0/xx unknown
- 1998-12-11 AR ARP980106296A patent/AR009212A1/es unknown
- 1998-12-11 EP EP98959187A patent/EP0970954A4/fr not_active Withdrawn
- 1998-12-11 US US09/367,242 patent/US6235730B1/en not_active Expired - Fee Related
- 1998-12-11 AU AU15068/99A patent/AU717963B2/en not_active Ceased
- 1998-12-11 CN CN98803899A patent/CN1252068A/zh active Pending
- 1998-12-11 ID IDW991010A patent/ID23439A/id unknown
- 1998-12-14 PE PE1998001218A patent/PE20000054A1/es not_active Application Discontinuation
-
1999
- 1999-08-11 NO NO993868A patent/NO993868L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU717963B2 (en) | 2000-04-06 |
ID23439A (id) | 2000-04-20 |
WO1999031085A1 (fr) | 1999-06-24 |
PE20000054A1 (es) | 2000-02-09 |
AU1506899A (en) | 1999-07-05 |
NZ337118A (en) | 2000-03-27 |
BR9807339A (pt) | 2000-03-21 |
IL131319A0 (en) | 2001-01-28 |
CN1252068A (zh) | 2000-05-03 |
CA2280705A1 (fr) | 1999-06-24 |
TR199901933T1 (xx) | 2000-03-21 |
AR009212A1 (es) | 2000-04-12 |
EP0970954A1 (fr) | 2000-01-12 |
HUP0001154A2 (hu) | 2001-04-28 |
KR20000070983A (ko) | 2000-11-25 |
JP2959765B2 (ja) | 1999-10-06 |
NO993868D0 (no) | 1999-08-11 |
EP0970954A4 (fr) | 2001-01-10 |
JPH11228569A (ja) | 1999-08-24 |
HUP0001154A3 (en) | 2001-06-28 |
SK109399A3 (en) | 2000-01-18 |
US6235730B1 (en) | 2001-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO993868L (no) | 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme | |
TR200202200T2 (tr) | Glükopiranosiloksibenzilbenzen türevleri, bu türevleri ihtiva eden tıbbi bileşimler ve türevlerin hazırlanması için ara-maddeler. | |
Rubino et al. | Biphenyl sulfonylamino methyl bisphosphonic acids as inhibitors of matrix metalloproteinases and bone resorption | |
NO20014225L (no) | Nye sykliske tetrapeptid-derivater og anvendelse av dem som legemidler | |
TW200800988A (en) | Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity | |
NO20074310L (no) | Spiroketalderivat og anvendelse derav som diabetesmedisin | |
NO20051411L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav | |
NO20054331L (no) | Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater | |
EP1736467A4 (fr) | Nouveau derive sulfonamide | |
NO20065573L (no) | Orto-substituerte aryl eller heteroarylamidforbindelser | |
NO20023688L (no) | Integrinekspresjonsinhibitorer | |
NO20052802L (no) | Pyrrolopyrimidinderivativer | |
DK0870765T3 (da) | Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen | |
MXPA04001016A (es) | Derivados de sulfonamida como inhibidores de la gamma secretasa. | |
DK0874812T3 (da) | Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf | |
NO20054330L (no) | 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater | |
NO20055921L (no) | Heterocykliske metylsulfonderivater | |
NO973635L (no) | Fremgangsmåte for hemming av celle-celle adhesjon | |
RS49906B (sr) | Benzociklohepteni, postupak za njihovo dobijanje, farmaceutski preparati koji ove sadrže kao i njihova primena za izradu lekova | |
AU4396899A (en) | Remedies for diabetes | |
DE50011034D1 (de) | N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
ES2011427T3 (es) | Derivados de la oxima de octahidronaftaleno para la inhibicion de la sintesis del colesterol, procedimientos para su preparacion y composiciones que los contienen. | |
DE69814800D1 (de) | Epoxysuccinamid-derivate oder ihre salze | |
NO980694L (no) | Sulfonamidsubstituerte kromaner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostika såvel som medikamenter inneholdende dem | |
EA200000389A3 (ru) | Новые замещенные пиридины или пиперидины, способ их получения и содержащие их фармацевтические композиции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |